Open-label, multiple-dose, drug interaction study to assess the effect of famotidine with or without tenofovir on the pharmacokinetics of atazanavir when given with ritonavir in HIV-infected subjects
Phase of Trial: Phase IV
Latest Information Update: 17 Nov 2014
At a glance
- Drugs Atazanavir (Primary) ; Famotidine; Ritonavir; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 10 Jun 2017 Biomarkers information updated
- 05 Nov 2008 Actual patient number (40) added as reported by ClinicalTrials.gov.
- 07 Apr 2008 Actual study completion date December 2007 added as reported by ClinicalTrials.gov.